Remelteon
Inquiry
| Post Date: | Mar 24,2017 |
| Expiry Date: | Mar 24,2018 |
| Detailed Description: | Cas No. :196597-26-9 Remelteon is a new molecule drug, Japan (TAKEDA) developed for the treatment of difficult to sleep Insomnia and chronic insomnia and short-term insomnia. |
| CAS Registry Number: | 196597-26-9 |
| Synonyms: | ;N-{2-[(8S)-1,6,7,8-Tetrahydro-2H-indeno[5,4-b]fur-8-yl]ethyl}propanamid;N-{2-[(8S)-1,6,7,8-tétrahydro-2H-indéno[5,4-b]fur-8-yl]éthyl}propanamide;N-{2-[(8S)-1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl}propanamide;propanamide, N-[2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl]-; |
| Molecular Formula: | C16H21NO2 |
| Molecular Weight: | 259.3434 |
| Molecular Structure: | 
|
| Company: | HangZhou DoEasy Pharma Co.,Ltd. [ China ] |
| Contact: | Ms Xu |
| Tel: | 0086-571-88992753 |
| Fax: | 0086-571-28890605 |
| Email: | sales@deasypharma.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
